Author:
Doweck Ilana,Robbins K Thomas,Samant Sandeep,Vieira Francisco
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Bourhis J, Amand C, Pignon JP, MACH-NC Collaborative Group: Update of MACH-NC (meta-analysis of chemotherapy in head & neck cancer) database focused on concomitant chemotherapy [abstract 5505]. Proc ASCO. 2004, 22 (14S): 489-
http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=26&abstractID=3198
2. Adelstein DJ, Li Y, Adams GL, Wagner H, Kish JA, Ensley JF, Schuller DE, Forastiere AA: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003, 21: 92-98. 10.1200/JCO.2003.01.008.
3. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 349: 2091-2098. 10.1056/NEJMoa031317. 2003 Nov 27
4. Robbins KT, Kumar P, Wong FSH, Hartsell WF, Flick P, Palmer R, Weir AB, Neill HB, Murry T, Ferguson R, Hanchett C, Vieira F, Bush A, Howell SB: Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000, 22: 687-693. 10.1002/1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W.
5. Doweck I, Robbins KT, Vieira F: Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2001, 127: 1315-1318.